MAPT and Alzheimer disease: These studies suggest that both Aβ and Tau can affect excitatory neurons and GABA inhibitory interneurons during AD development, probably via different mechanisms, but ultimately disturbing the balance between neuronal excitation and inhibition (Lei et al., 2016; Fu Y. et al., 2019).